Heart Disease Trial, Recruiting (NCT07184541)

Heart Disease Trial, Recruiting NCT07184541 Sponsor: Lee Anne Siegmund Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07184541 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 55 years or older
People who have been diagnosed with heart failure, whether recently or some time ago
People who are currently in hospital receiving treatment for heart failure symptoms, such as water tablets given through a drip, being asked to limit fluid intake, or being put on a low-salt diet
People who are able to read and communicate in English
People who are able to stand and weigh themselves independently
People who have a set of scales at home, or for whom obtaining a set of scales for the study is possible

Who may not be able to join:

People who have a documented diagnosis of cognitive impairment (such as dementia or a memory condition)
People with a high number of serious other health conditions alongside their heart failure, as measured by a scoring system called the Charlson Comorbidity Index — specifically, those with a score greater than 4 (confirm with trial site if unsure how this applies)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 216-618-5126

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07184541

Sponsor: Lee Anne Siegmund

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

Trial contact: 216-618-5126

More information: https://clinicaltrials.gov/study/NCT07184541

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 55 years or older
People who have been diagnosed with heart failure, whether recently or some time ago
People who are currently in hospital receiving treatment for heart failure symptoms, such as water tablets given through a drip, being asked to limit fluid intake, or being put on a low-salt diet
People who are able to read and communicate in English
People who are able to stand and weigh themselves independently
People who have a set of scales at home, or for whom obtaining a set of scales for the study is possible

Who may not be able to join:

People who have a documented diagnosis of cognitive impairment (such as dementia or a memory condition)
People with a high number of serious other health conditions alongside their heart failure, as measured by a scoring system called the Charlson Comorbidity Index — specifically, those with a score greater than 4 (confirm with trial site if unsure how this applies)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Lee Anne Siegmund

Registry

ClinicalTrials.gov

Start date

1 November 2024

Est. completion

31 October 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Project Feasibility-fidelity; Project feasibility-use of tool; Project feasibility-recruitment; Project feasibility-randomization; Project feasibility-appropriateness of SCHFI; Project feasibility-appropriateness of KCCQ

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov